key: cord-0746669-ghfd0vtm
authors: Candal-Pedreira, Cristina; Pérez-Ríos, Mónica; Ruano-Ravina, Alberto
title: Comparison of COVID-19 and non-COVID-19 papers
date: 2022-04-27
journal: Gac Sanit
DOI: 10.1016/j.gaceta.2022.03.006
sha: 84350be4b26c6bf78fe5aec0f9af385013ec4eb7
doc_id: 746669
cord_uid: ghfd0vtm

Objective: The need to generate evidence related to COVID-19, the acceleration of publication and peer-review process and the competition between journals may have influenced the quality of COVID-19 papers. Our objective was to compare the characteristics of COVID-19 papers against those of non-COVID-19 papers and identify the variables in which they differ. Method: We conducted a journal-matched case-control study. Cases were COVID-19 papers and controls were non-COVID-19 papers published between March 2020 and January 2021. Journals belonging to five different Journal Citations Reports categories were selected. Within each selected journal, a COVID-19 paper (where there was one) and another non-COVID-19 paper were selected. Conditional logistic regression models were fitted. Results: We included 81 COVID-19 and 143 non-COVID-19 papers. Descriptive observational studies and analytical observational studies had, respectively, a 55-fold (odds ratio [OR]: 55.12; 95% confidence interval [95%CI]: 7.41-409.84) and 19-fold (OR: 19.28; 95%CI: 3.09-120.31) higher likelihood of being COVID-19 papers, respectively, and also a higher probability of having a smaller sample size (OR: 7.15; 95%CI: 2.33-21.94). COVID-19 papers had a higher probability of being cited since their publication (OR: 4.97; 95%CI: 1.63-15.10). Conclusions: The characteristics of COVID-19 papers differed from those of non-COVID-19 papers published in the first months of the pandemic. In order to ensure the publication of good scientific evidence the quality of COVID-19-papers should be preserved.

Since January 2020, the disease caused by the new coronavirus (SARS-CoV-2), named COVID-19 by the World Health Organization, has spread rapidly causing a global pandemic, with multifold consequences and giving rise to an unprecedented worldwide health and economic crisis in times of peace. 1, 2 The interest aroused by the new coronavirus, added to the urgent need to generate evidence about the disease and its treatment, among other things, has led to an exponential increase in COVID-19-related papers. 3 This has in turn produced an avalanche of information difficult to manage and apply, whether by health professionals or by bodies tasked with implementing public health policies. 4 In the period from the outbreak of the pandemic to May 2021, a total of 419,950 publications on COVID-19 were published, and of these more than 47,000 (11.2% of the total) were pre-prints, i.e., publications published online before peer review (www.dimensions.ai/covid19). Both peer-reviewed papers and preprints have served to generate a great volume of information on COVID-19.

Yet it has been observed that a substantial number of peer-reviewed papers have methodological limitations or give rise to erroneous conclusions, with the resulting potential harmful effect for public health. 5, 6 The need to generate evidence quickly in the case of COVID-19, coupled with the competition between scientific journals to be first to publish what might prove to be the results of greatest relevance, may have undermined the quality papers, due to pressure to publish. [8] [9] [10] Evidence of the change in the editorial process can be seen in the number of retractions observed in COVID-19 papers. 7 By May 2021, a total of 108 COVID-19-related papers had been retracted according to the Retraction Watch database (www.retractiondatabase.org). Bearing in mind that the mean time for retracting a paper is long, this may probably be only the tip of the iceberg. What is more, the publication of papers which address other relevant scientific topics may well be affected by the lack of space for publishing them.

Since the outbreak of the pandemic, a number of authors have published bibliometric analyses aimed at describing the characteristics of COVID-19related studies and analyzing publication trends. 3, 4, [8] [9] [10] [11] [12] [13] Only one study has analyzed the quality of COVID-19 papers, comparing it against that of non-COVID-19 papers, using a case-control design covering the initial months of the pandemic. 14 A comparative analysis of papers on COVID-19 with respect to those on other topics published in the same journals (therefore controlling the role of editorial teams) could inform us about methodological differences that might influence or determine the quality of such studies. The objective of this study, therefore, was to compare the methodological and bibliometric characteristics of COVID-19 papers against those of non-COVID-19 papers and identify the variables in which the two differed, using a purpose-made case-control design.

Page 6 of 23 J o u r n a l P r e -p r o o f 6 We conducted a case-control study of published papers matched by journal of publication of the included papers. Cases were papers on COVID-19 published from March 2020 through January 2021, and controls were papers published during the same period on other topics in the same journal. A minimum of one control was matched with each case. The number of controls per case varies between one and ten, depending on the number of COVID-19 and non-COVID-19 papers published by the selected journals.

We selected indexed journals profiled in Journal Citation Reports (JCR), belonging to the categories "Respiratory System", "Infectious Diseases", "Public, Environmental and Occupational Health", "General/Internal Medicine" and "Oncology". We selected the four journals with the higher impact factor of each quartile from each category, yielding a total of 20 scientific journals (5 categories × 4 quartiles). As inclusion criterion, all journals selected were required to have published one issue per month and to publish original papers in English, Spanish or Portuguese. For each journal selected, we reviewed all the monthly issues published from March 2020 through January 2021.

From each issue included, we selected one COVID-19 paper and one non-COVID-19 paper by order of appearance. In any case, should a given number might not contain a COVID-19 paper that fulfilled the inclusion criteria, this was selected from another issue of the same journal. Hence, the first of the COVID-19 papers of that particular issue of the journal was extracted for the month of publication in question, and a second paper was then selected for the issue of journals which did not contain a COVID-19 paper.

By way of inclusion criterion, papers were required to report on original research conducted on human beings and be written in English, Spanish or Portuguese.

We excluded modeling studies, case studies, ecological studies and qualitative studies. Retracted papers were not included.

Due to the nature of the study, ethics committee approval was not required. Furthermore, the following design variables were sourced from each paper: study design, categorized as descriptive observational (cross-sectional and cases series studies), analytical observational (case-control and cohort studies) or experimental (quasi-experimental and clinical trials); sample size (1-500, >500); study scope (local, national or international); number of centers at which the study was undertaken (unicenter or multicenter); and number of adjustment variables.

All the above variables were entered into a database purpose-designed by the authors.

Page 8 of 23 J o u r n a l P r e -p r o o f 8 We performed a descriptive statistical analysis to identify the characteristics of the papers included, by reference to the variables of interest collected and case or control status. Quantitative variables were expressed in terms of median and interquartile range, while qualitative variables were expressed in absolute and relative frequencies.

A multivariate conditional logistic regression model was fitted to identify the bibliometric and design variables associated with COVID-19 or non-COVID-19

papers. In the final model the following variables were included: study design (descriptive observational, analytical observational, experimental) and sample size (1-500, >500). In addition, the model was adjusted by the journal in which the articles where published. Adjusted odds ratios (OR) were calculated along with their 95% confidence intervals (95%CI).

Values were deemed statistically significant at p <0.05. All statistical analyses were performed using the Stata v14.1. computer software program. For analysis purposes, we excluded non-COVID-19 papers published in the seven journals which had not published any COVID-19 paper, due to the impossibility of matching these controls with cases by reference to the journal.

Finally, the analysis included a total of 224 papers published in 13 journals; of these, 81 were COVID-19 papers and 143 were non-COVID-19 papers (Fig. 1) . Table 1 

The results observed in this study suggest that there are differences among original research papers published in the first months of the pandemic, according to whether they report COVID-19 or non-COVID-19 studies. Despite receiving more citations, COVID-19 studies are more likely to have certain characteristics (study design, sample size) which are generally associated with low methodological quality than are non-COVID-19 studies, according to some quality assessment tools, such as GRADE. 15 The process of scientific publication has been influenced by the COVID-19

pandemic. On the one hand, in line with the results of this study, a number of authors had already found evidence to show that time to publication is significantly shortened in the case of COVID-19 papers, in comparison with papers on other scientific topics. 7, 16, 17 This phenomenon is the result of scientific journals expediting the publication process and peer review of COVID-19 papers, with the aim of disseminating results more quickly. The results of the study conducted by Horbach indicate that COVID-19 papers are accepted after a single peer-review round, whereas non-COVID-19 papers require more rounds before being accepted by the journal, thus increasing the time between manuscript submission and publication. 16 In this context, doubts arise as to whether editorial teams apply the same quality criteria when it comes to evaluating COVID-19 and non-COVID-19 articles.

Added to this is the fact that, according to our results, COVID-19 studies published in the first months of the pandemic have a greater likelihood of having a descriptive design and smaller sample size than do non-COVID-19 papers.

Different studies have analyzed the quality of COVID-19 papers using different methods and all agree on the fact that, generally speaking, their quality is low. 14,17,18 Accorsi et al. 19 have identified many biases in COVID-19-related observational studies in aspects such as interpretation of results or enrollment of a non-representative sample of the study population, among others. This poses a problem, since papers with a low methodological quality and a greater presence of biases can induce readers to draw erroneous conclusions, which is, in itself, a potential health threat. Associated with this is the fact that health professionals may base themselves on erroneous or invalid conclusions to guide their clinical practice, with the potential harm that this entails for patients; similarly, the health authorities could take decisions which might endanger population health. 20, 21 Mention should be made of the great popularity enjoyed by preprint servers during the pandemic. The use of preprint servers had already been on the rise before the pandemic, due to the criticisms leveled at scientific journals' current publication system, and peer review in particular, for slowing down the dissemination of results. In the context of the pandemic, a considerable number of COVID-19-related manuscripts were published as preprints. 7, 22 It should be borne in mind that there is no mechanism which would verify that information published as a preprint is in fact genuine and reliable. 6 During the pandemic, results published in the form of preprints have led some political and medical personalities to promote certain treatments for COVID-19, without these having been validated in any way, with the potential harm that this could entail for the population. 5, 22 A formal approach to the role of preprints in COVID-19 pandemic is clearly needed.

It should be noted that only 3.5% of COVID-19 studies included in the analysis had an experimental design versus 29.4% in the case of non-COVID-19 studies. During the first months of the pandemic, it was common for studies to have an observational design and small sample size, thus making them methodologically inferior. 23 With the passage of time, however, it is to be hoped that COVID-19-related studies may improve their methodological quality, since higher-quality studies require better planning and execution and, thus, more time. 4 Even so, the results of our study highlight the fact that almost one year after the outbreak of the pandemic, the number of experimental studies published on COVID-19 is still low in comparison with non-COVID-19 studies.

Another worrying phenomenon is the impact and visibility of COVID-19 studies.

The results indicate that COVID-19 papers accumulate a higher number of citations than do non-COVID-19 papers. Our results are in line with the study conducted by Yang et al. 18 The information which has been published on COVID-19 does not always make for any real advance in scientific knowledge. Encouragement should be given to the publication of systematic literature reviews which compile and summarize the information generated on different aspects of COVID-19, with the aim of making it more manageable. 4 It should likewise be borne in mind that there is an unnecessary overlapping of COVID-19-related scientific evidence, with the ensuing loss of time and resources (human and economic) that this entails. 5, 21, 24 However, there are COVID-19-related fields that are hardly being studied, such as the effects of the pandemic on other diseases or the use of new technologies. 11 One solution to this problem could be the pre-registration of studies on purpose-designed platforms. 6 It should also be noted that by prioritizing the publication of COVID-19 studies, relevant higher-quality studies addressing other scientific topics might possibly be overlooked or even ruled out.

It is important that editors be more alert to the quality of COVID-19 papers submitted for publication by using of checklists, such as STROBE or CONSORT 25 or by enhancing open peer reviews, making it known what reviews have been conducted and by whom these have been conducted. Open peer reviews could have some benefits as it might increase the transparency of the peer review process by shifting the responsibility to reviewers to perform more thoughtful reviews. Also, open peer review enables greater visibility for peer review activities. 26 It is worth mentioned that most authors, reviewers, and editors are in favor of this type of peer review, especially among younger generations. However, a large number of authors also believe that open identities could lead to worse and less critical peer reviews, mostly because of the potential consequences from the aggrieved authors. 27 Another strategy could be the promoting of unsolicited reviews carried out spontaneously after the publication of the paper in a peer reviewed journal as it might favor early detection of errors or scientific misconduct in all scientific papers, and not only in those pertaining to This paper has some limitations. On the one hand, the sample size is small for the design used. This is due to the inclusion criterion which determines the selection of original research studies. Rather than being original research studies, a good part of the COVID-19 articles published to date are in the form of letters or editorials. 3 We, however, chose to include original papers only, One of the strengths of this study is its design, established to favor comparison of the quality of studies in a single journal across the period analyzed, as well as between quartiles of different areas of JCR knowledge. This design facilitates comparison between COVID-19 and non-COVID-19 papers.

In conclusion, characteristics of COVID-19 papers differed from those of non-COVID-19 papers published in the first months of the pandemic. Many of the aspects relating to COVID-19 remain unknown, despite the effort of the scientific community to generate and disseminate information about the disease. Hence, more evidence of better quality must be generated with the aim of guiding decision-making in the context of the pandemic. That said, however, the urgency with which information is needed is no excuse for conducting lowquality research, which is ultimately of little use, leads to a waste of research resources, and may even pose a health threat and/or undermine scientific credibility. For all the above-mentioned reasons, measures are required that guarantee and improve the quality of COVID-19-related research studies. Adjusted by the study design, sample size and the journal where the article was published.

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)

Bibliometric analysis of global scientific research on Coronavirus (COVID-19)

Evaluating trends in COVID-19 research activity in early 2020: the creation and utilization of a novel openaccess database

Waste in covid-19 research

Open science saves lives: lessons from the COVID-19 pandemic

Preliminary analysis of COVID-19 academic information patterns: a call for open science in the times of closed borders

Scientometric trends for coronaviruses and other emerging viral infections

Meursinge Reynders R. Characteristics of scientific articles on COVID-19 published during the initial 3 months of the pandemic

A Bibliometric analysis of COVID-19 research activity: a call for increased output

Coronavirus disease 2019 (COVID-19): an evidence map of medical literature

Pandemic publishing poses a new COVID-19 challenge

Mapping the situation of research on coronavirus disease-19 (COVID-19): a preliminary bibliometric analysis during the early stage of the outbreak

Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: a case control study

GRADE System: classification of quality of evidence and strength of recommendation

No time for that now! Qualitative changes in manuscript peer review during the Covid-19 pandemic

Methodological quality of COVID-19 clinical research

Quality of early evidence on the pathogenesis, diagnosis, prognosis and treatment of COVID-19

How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19

Evidence based medicine manifesto for better healthcare

Avoidable waste in the production and reporting of research evidence

Preprints involving medical research -do the benefits outweigh the challenges?

Research methodology and characteristics of journal articles with original data, preprint articles and registered clinical trial protocols about COVID-19

Are too many scientists studying Covid? Knowable Mag Annu Rev

ESE and EASE call for high standards of research and editing

Ten considerations for open peer review

Survey on open peer review: Attitudes and experience amongst editors, authors and reviewers